简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Video
Research
HOME
·
Guotai Gold Stock ETF
Guotai Gold Stock ETF (517400) Falls 0.53%, with Scale Growing by RMB 148 Million Over the Past Week
Tags:
ETF
517400.SH
Guotai Gold Stock ETF
2026-08-11
Guotai Gold Stock ETF (517400) Rises 1.75%, Poised for 4 Consecutive Gains.** NewTimeSpace (newtimespace.com) News, – As of 10:26 on August 10, 2026, Guotai Gold Stock ETF (517400) rose 1.75%, poised for 4 consecutive gains, with its latest price at RMB
Tags:
ETF
517400.SH
Guotai Gold Stock ETF
2026-08-10
Guotai Gold Stock ETF (517400) Rises 3.24%, Poised for 3 Consecutive Gains
Tags:
ETF
517400.SH
Guotai Gold Stock ETF
2026-07-31
Guotai Gold Stock ETF (517400) Rises 2.70%, with Scale Growing by RMB 63.3972 Million Over the Past 2 Weeks
Tags:
ETF
517400.SH
Guotai Gold Stock ETF
2026-07-30
Guotai Gold Stock ETF (517400) falls 3.36%, with the latest net outflow of 7.4061 million yuan
Tags:
ETF
517400.SH
Guotai Gold Stock ETF
2026-07-24
Featured News
Finance
New round of southbound Stock Connect target adjustments: 54 added, 15 removed
Finance
HBM HOLDINGS-B (02142.HK): Shares Added to Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect Lists, Effective 7 September 2026
Finance
TENNOR THERAP-B (06872.HK): Positive Phase IIa Proof-of-Concept Data for Rifaquizalone (TNP-2092) in Prosthetic Joint Infection; Multicenter Phase IIb Initiated
Finance
CSTONE PHARMA-B (02616.HK): Shares Added to Stock Connect Eligible List, Effective 7 September 2026
Finance
FOSUN PHARMA (02196.HK): Sells 6% Stake in India's Gland Pharma for Approximate USD 294 Million
Finance
PICC GROUP (01339.HK): Nominates Ms. Yang Dongning as Candidate for Executive Director of the Fifth Session of the Board
Finance
KEYMED BIO-B (02162.HK): Non-Executive Director Dr. Wang Minchuan Resigns, Effective 4 September 2026
Finance
KINTOR PHARMA-B (09939.HK): Long-Term Safety Trial of KT-939 Completed; No Skin Adverse Reactions in 114 Subjects Over 52 Weeks
Finance
RIVERINE CHINA (01417.HK): Public Float Falls to 23.85%, Below the 25% Minimum; Restoration Expected Within 6 Months
Finance
CLOVER BIO-B (02197.HK): Positive Phase II Data for Respiratory Combo Vaccine Candidates in Australian Elderly
Scan QR Code
Download App